Exosome Therapy in Staten Island

Exosome Therapy at our Staten Island, NY location brings the leading edge of regenerative medicine directly to Staten Island patients, delivering concentrated biological signals that direct tissue repair and reduce chronic inflammation at the cellular level.

The Most Advanced Regenerative Option, Now on Staten Island

Regenerative medicine continues to evolve, and exosome therapy represents one of its most sophisticated developments. Rather than delivering cells or platelets, exosomes target the communication layer of biological healing, carrying the precise molecular signals that instruct the body's own cells to repair damaged tissue and reduce chronic inflammation.

For Staten Island patients seeking the most advanced non-surgical option for spine and musculoskeletal conditions, Gerling Spine Care and Research Institute offers exosome therapy within a clinical program grounded in scientific rigor and honest, individualized care, now available close to home. Contact our Staten Island office today to learn more about Exosome Therapy and whether it may be right for you.

What Is Exosome Therapy?

Exosomes are nanoscale extracellular vesicles released naturally by cells throughout the body. They function as biological messengers, carrying proteins, lipids, and genetic material, including RNA, between cells to regulate tissue repair, immune modulation, and inflammation control.

How Exosomes Differ From PRP and Bone Marrow Aspirate

PRP and bone marrow aspirate concentrate healing agents from the patient's own blood or marrow. Exosomes used in therapy are typically derived from donor-sourced mesenchymal stem cells and produced under carefully controlled laboratory conditions.

Rather than delivering platelets or whole cells, exosomes deliver a concentrated payload of biological signals, including growth factors, cytokines, and regulatory RNA molecules that instruct the body's own cells to initiate and sustain the repair process.

Because exosomes are acellular, containing no living cells, they carry a distinct risk and regulatory profile compared to cell-based therapies. They can also be produced with a high degree of biological consistency, making them a reliable and reproducible tool within a comprehensive regenerative care program.

Where Exosome Therapy Fits in Our Regenerative Program

At Gerling Spine Care and Research Institute, exosome therapy is one component of a broader regenerative medicine philosophy that includes PRP, bone marrow aspirate, and disc cell therapies. It may be used independently or in combination with other biologics, depending on the nature, location, and severity of the condition being treated.

Our Staten Island team determines the most appropriate approach through a thorough individual evaluation rather than a standardized protocol.

We’re here to help you move forward.

Medical professional wearing gloves preparing a syringe

Conditions Treated With Exosome Therapy

Exosome therapy is used to support healing and reduce pain across a range of spinal and musculoskeletal conditions, including:

Degenerative disc disease of the cervical or lumbar spine
Herniated or bulging discs
Spinal arthritis and facet joint degeneration
Sacroiliac joint dysfunction
Osteoarthritis of the spine, hip, knee, or shoulder
Chronic tendinopathy and soft tissue injuries
Ligament injuries and cartilage damage
Sports-related musculoskeletal conditions

It is particularly relevant for patients who have not achieved adequate or lasting results from PRP or conventional injection therapies, or those seeking the most advanced non-surgical regenerative option available.

Are You a Candidate for Exosome Therapy in Staten Island?

Exosome therapy may be appropriate for adults with confirmed musculoskeletal or spinal conditions who are seeking a non-surgical regenerative approach and have not achieved satisfactory results from conventional treatments, including physical therapy, standard injections, or other biologics. It is generally not appropriate for patients with active infections, certain autoimmune disorders, active malignancy, or those on immunosuppressive medications.

Because exosome therapy is an emerging field, patient selection and honest expectation-setting are particularly important. Our Staten Island team will take the time to walk through the current evidence, explain what exosome therapy can and cannot realistically achieve, and determine whether it fits appropriately within your broader treatment plan.

What to Expect From Exosome Therapy in Staten Island

Exosome therapy is a minimally invasive outpatient procedure with minimal downtime and a straightforward recovery.

Before Your Exosome Therapy

Your consultation will include a detailed review of your condition, imaging, and prior treatments. Our team will explain the procedure clearly, set realistic expectations about the timeline and degree of improvement, and address all questions before any decision is made. Any relevant pre-procedure instructions regarding medications will be provided at this time.

The Day of Your Surgery

The procedure involves the injection of prepared exosomes directly into the target area under imaging guidance. It does not require general anesthesia and is typically completed in under an hour. Unlike procedures requiring bone marrow harvest, there is no additional collection step involved, making the appointment efficient and comfortable for most patients.

Recovering After Your Procedure

Most patients return to light activities shortly after the procedure. Some temporary soreness at the injection site is normal and resolves within a few days. Improvement is gradual, reflecting the biological nature of the healing process. Most patients begin to notice meaningful benefit within four to eight weeks, with continued progress over the months that follow.

Our team monitors your response and discusses whether additional or complementary treatments are appropriate as part of your ongoing care.

Why Choose Gerling Spine Care and Research Institute?

Offering exosome therapy responsibly requires more than product access. It requires a clinical team that understands the underlying biology, monitors the evolving regulatory and evidence landscape, and applies the therapy only where it is genuinely likely to benefit the patient.

At Gerling Spine Care and Research Institute, that standard of intellectual honesty and scientific engagement defines our approach to every regenerative treatment we offer. For Staten Island patients, that level of clinical rigor is now available close to home.

Exosome Therapy Frequently Asked Questions

How are exosomes different from stem cells?

Stem cell therapy introduces living cells into the body with the goal of generating or repairing tissue. Exosome therapy delivers acellular vesicles that contain biological signaling molecules but no living cells. This reduces certain risks associated with cell-based therapies and allows for easier standardization and storage, while still delivering many of the regenerative signals that stem cells produce without introducing live cells.

Is exosome therapy FDA-approved?

Exosome therapy exists in an evolving regulatory category. The FDA permits certain exosome-related treatments under specific guidelines, and reputable providers follow strict FDA-compliant sourcing and processing standards. Your provider should clearly explain the regulatory status of any specific exosome protocol being recommended.

How does exosome therapy compare to PRP?

PRP concentrates growth factors from the patient’s own blood, while exosomes deliver a broader range of cellular signaling molecules, including proteins and regulatory RNA that influence cellular behavior. Depending on the condition, exosomes may provide a stronger regenerative signal, and in some cases they may be combined with PRP for an enhanced effect.

How many exosome treatments will I need?

Many patients start with a single treatment and are monitored over time to determine whether additional sessions are needed. The number of treatments depends on the condition being treated, its severity, and the individual’s biological response.

Is exosome therapy covered by insurance?

No. Exosome therapy is generally not covered by insurance and is considered investigational or elective regenerative medicine. Pricing and expectations are discussed during consultation so patients can make fully informed decisions before proceeding.